Barclays PLC Accelerate Diagnostics, Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.54 - $1.41 $2,982 - $7,788
-5,524 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.4 - $5.15 $48,323 - $177,762
-34,517 Reduced 86.2%
5,524 $7,000
Q4 2021

Feb 14, 2022
BUY
$4.27 - $6.97 $113,411 - $185,123
26,560 Added 197.02%
40,041 $209,000
Q3 2021

Nov 09, 2021
BUY
$5.31 - $8.25 $48,586 - $75,487
9,150 Added 211.27%
13,481 $79,000
Q2 2021

Aug 13, 2021
SELL
$6.81 - $9.23 $157,372 - $213,296
-23,109 Reduced 84.22%
4,331 $35,000
Q1 2021

May 13, 2021
BUY
$7.99 - $15.0 $74,155 - $139,215
9,281 Added 51.11%
27,440 $228,000
Q4 2020

Feb 11, 2021
SELL
$7.04 - $11.7 $307,134 - $510,435
-43,627 Reduced 70.61%
18,159 $138,000
Q3 2020

Nov 12, 2020
SELL
$9.98 - $18.04 $48,213 - $87,151
-4,831 Reduced 7.25%
61,786 $659,000
Q2 2020

Aug 12, 2020
BUY
$7.49 - $15.16 $270,748 - $548,003
36,148 Added 118.64%
66,617 $1.01 Million
Q1 2020

May 13, 2020
SELL
$4.62 - $18.74 $1,903 - $7,720
-412 Reduced 1.33%
30,469 $254,000
Q4 2019

Feb 10, 2020
SELL
$14.6 - $18.13 $532,885 - $661,726
-36,499 Reduced 54.17%
30,881 $522,000
Q3 2019

Nov 14, 2019
BUY
$16.62 - $23.92 $4,138 - $5,956
249 Added 0.37%
67,380 $1.25 Million
Q2 2019

Aug 14, 2019
BUY
$17.79 - $22.88 $168,364 - $216,536
9,464 Added 16.41%
67,131 $1.54 Million
Q1 2019

May 15, 2019
BUY
$11.76 - $22.15 $47,051 - $88,622
4,001 Added 7.46%
57,667 $1.21 Million
Q4 2018

Feb 14, 2019
BUY
$10.42 - $21.94 $418,811 - $881,834
40,193 Added 298.32%
53,666 $617,000
Q3 2018

Nov 14, 2018
BUY
$20.4 - $24.6 $235,885 - $284,449
11,563 Added 605.39%
13,473 $309,000
Q2 2018

Aug 14, 2018
SELL
$19.02 - $24.95 $97,991 - $128,542
-5,152 Reduced 72.95%
1,910 $43,000
Q1 2018

May 15, 2018
BUY
$22.55 - $29.9 $66,048 - $87,577
2,929 Added 70.87%
7,062 $161,000
Q4 2017

Feb 14, 2018
SELL
$18.0 - $30.0 $39,978 - $66,630
-2,221 Reduced 34.95%
4,133 $108,000
Q3 2017

Nov 14, 2017
BUY
$21.1 - $25.15 $134,069 - $159,803
6,354
6,354 $143,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email